Sonesitatug vedotin is an antibody-drug conjugate containing a vedotin (MMAE) payload. Sonesitatug vedotin targets Claudin18.2. Sonesitatug vedotin can be used for ADC and oncology research.
* VAT and and shipping costs not included. Errors and price changes excepted